Inhibition of nuclear factor κB activation in PC3 cells by genistein is mediated via Akt signaling pathway

Clinical Cancer Research

Volumn 8, Issue 7, 2002, Pages 2369-2377

  Li, Yiwei ^a   Sarkar, Fazlul H ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; GENISTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN KINASE B; AKT1 PROTEIN, HUMAN; ANTINEOPLASTIC AGENT; DNA; GLYCOGEN SYNTHASE KINASE 3; ONCOPROTEIN; PROTEIN SERINE THREONINE KINASE;

APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL GROWTH; CELL SURVIVAL; CONTROLLED STUDY; DNA BINDING; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE CANCER; SIGNAL TRANSDUCTION; CELL CULTURE; CELL NUCLEUS; DRUG ANTAGONISM; DRUG EFFECT; GEL MOBILITY SHIFT ASSAY; MALE; METABOLISM; PATHOLOGY; PHOSPHORYLATION; PLASMID; PROSTATE TUMOR; SERODIAGNOSIS; WESTERN BLOTTING;

ANTICARCINOGENIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; CELL NUCLEUS; DNA; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GENISTEIN; GLYCOGEN SYNTHASE KINASE 3; HUMAN; MALE; NF-KAPPA B; PHOSPHORYLATION; PLASMIDS; PRECIPITIN TESTS; PROSTATIC NEOPLASMS; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; SIGNAL TRANSDUCTION; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TUMOR CELLS, CULTURED; HUMANS; PROTO-ONCOGENE PROTEINS C-AKT;

EID: 0035992417     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends
2. Soybean phytoestrogen intake and cancer risk
3. Nutritional and socioeconomic factors in relation to prostate cancer mortality: A cross-national study
4. Genistein, a specific inhibitor of tyrosine-specific protein kinases
5. A thousand and one protein kinases
6. Signal transduction by receptors with tyrosine kinase activity
7. Induction of apoptosis in breast cancer cells MDA-MB-231 by genistein
8. Induction of apoptosis and inhibition of c-erbB-2 in MDA-MB-435 cells by genistein
9. 2-M arrest, p21WAF1 up-regulation, and apoptosis in a non-small-cell lung cancer cell line
10. Genistein-induced cell cycle arrest and apoptosis in a head and neck squamous cell carcinoma cell line
11. Differential sensitivity of normal and malignant breast epithelial cells to genistein is partly mediated by p21(WAF1)
12. The natural tyrosine kinase inhibitor genistein produces cell cycle arrest and apoptosis in Jurkat T-leukemia cells
13. Genistein- induced up-regulation of p21WAF1, down-regulation of cyclin B, and induction of apoptosis in prostate cancer cells
14. Induction of differentiation and DNA strand breakage in human HL-60 and K-562 leukemia cells by genistein
15. Genistein inhibits NF-κB activation in prostate cancer cells
16. Maniatis a lesson in family values
17. Structure of the NF-κB p50 homodimer bound to DNA
18. Site-specific phosphorylation of IκBα by a novel ubiquitination-dependent protein kinase activity
19. Duration of nuclear NF-κB action regulated by reversible acetylation
20. An essential role for NF-κB in preventing TNF-α-induced cell death
21. NF-κB antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation
22. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB
23. The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase
24. Akt/protein kinase B isoforms are differentially regulated by epidermal growth factor stimulation
25. Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction
26. Mechanism of activation of protein kinase B by insulin and IGF-1
27. Regulation of cell death protease caspase-9 by phosphorylation
28. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor
29. NF-κB is a target of AKT in anti-apoptotic PDGF signalling
30. NF-κB activation by tumour necrosis factor requires the Akt serine-threonine kinase
31. Sellers Regulation of G1 progression by the PTEN tumor suppressor protein is linked to inhibition of the phosphatidylinositol 3-kinase/Akt pathway
32. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl- 4H-1-benzopyran-4-one (LY294002)
33. Wortmannin inhibits transcytosis of dimeric IgA by the polymeric immunoglobulin receptor
34. A retroviral oncogene, Akt, encoding a serine-threonine kinase containing an SH2-like region
35. Cloning, chromosomal localization, and expression analysis of the mouse Akt2 oncogene
36. Identification of a human Akt3 (protein kinase B γ) which contains the regulatory serine phosphorylation site
37. HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation
38. Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells
39. Cellular survival: A play in three Akts
40. Insulin activates protein kinase B, inhibits glycogen synthase kinase-3, and activates glycogen synthase by rapamycin-insensitive pathways in skeletal muscle and adipose tissue
41. Role of glycogen synthase kinase-3 in the phosphatidylinositol 3-kinase/Akt cell survival pathway
42. Signal transduction through β-catenin and specification of cell fate during embryogenesis
43. Dissociation of cytokine-induced phosphorylation of Bad and activation of PKB/akt: Involvement of MEK upstream of Bad phosphorylation
44. Induction of NF-κB by the Akt/PKB kinase
45. Roles of Akt/PKB and IKK complex in constitutive induction of NF-κB in hepatocellular carcinomas of transforming growth factor α/c-myc transgenic mice
46. High expression levels of nuclear factor κB, IκB kinase α, and Akt kinase in squamous cell carcinoma of the oral cavity
47. HER-2/neu blocks tumor necrosis factor-induced apoptosis via the Akt/NF-κB pathway